Stay tuned for more details, coming soon.
Gisbert Schneider is a full professor of Computer-Assisted Drug Design at ETH Zurich, where he spearheads research into integrating AI and machine-learning methods into contemporary drug discovery. His career spans from the Pharmaceuticals Division at Roche to academia, initially at Goethe University in Frankfurt before assuming his current position at ETH Zurich. From 2021 to 2023, he served as the Director of the Singapore-ETH Centre. He is credited with introducing the concept of AI-based drug design and is renowned for coining the term "scaffold hopping". His extensive body of work includes over 450 scientific papers. Gisbert has co-founded several startup companies and serves as a consultant to the chemical and life science industry. His contributions to AI in drug discovery have garnered widespread acclaim, including the Ernst Schering Prize, Herman Skolnik Award, and the Gmelin-Beilstein Medal.
